What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Internal medicine, Pathology, IgG4-related disease, Immunology and Disease.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
His research integrates issues of Giant cell arteritis, Vasculitis, Clinical trial and Etanercept in his study of Surgery.
His study in IgG4-related disease is interdisciplinary in nature, drawing from both Subspecialty, Eosinophilia, Autoantibody, Autoimmune pancreatitis and Histopathology.
His Immunology research is multidisciplinary, incorporating elements of Genetics and Anti-neutrophil cytoplasmic antibody.
His Disease study integrates concerns from other disciplines, such as Pathological, Epidemiology, Bioinformatics, Submandibular gland and Immunoglobulin E.
His most cited work include:
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2901 citations)
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (1616 citations)
- IgG4-related disease. (1603 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Immunology, Vasculitis, Pathology and Disease.
His biological study spans a wide range of topics, including Gastroenterology and Surgery.
His Immunology study frequently links to adjacent areas such as ANCA-Associated Vasculitis.
His research in Vasculitis intersects with topics in Vascular disease and Rituximab.
His studies deal with areas such as Cyclophosphamide and Azathioprine as well as Rituximab.
His Disease research focuses on IgG4-related disease in particular.
He most often published in these fields:
- Internal medicine (29.22%)
- Immunology (21.82%)
- Vasculitis (21.06%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (29.22%)
- Tocilizumab (8.54%)
- Giant cell arteritis (12.71%)
In recent papers he was focusing on the following fields of study:
John H. Stone mainly investigates Internal medicine, Tocilizumab, Giant cell arteritis, Prednisone and Disease.
His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Urinary system.
He has researched Tocilizumab in several fields, including Placebo, Randomized controlled trial and Discontinuation.
The study incorporates disciplines such as Dermatology, Adverse effect and Incidence in addition to Giant cell arteritis.
In his research, Prednisolone is intimately related to Glucocorticoid, which falls under the overarching field of Prednisone.
His biological study focuses on IgG4-related disease.
Between 2018 and 2021, his most popular works were:
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. (303 citations)
- The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease (116 citations)
- Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts (87 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
John H. Stone focuses on Internal medicine, Disease, Vasculitis, Giant cell arteritis and IgG4-related disease.
His Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology.
His Disease research incorporates themes from Effective treatment, Advanced stage, Pathophysiology, Fibrosis and Positron emission tomography.
John H. Stone has included themes like Tocilizumab and Prednisone in his Giant cell arteritis study.
In his research on the topic of IgG4-related disease, Thyroiditis and Autoimmune pancreatitis is strongly related with Retroperitoneal fibrosis.
John H. Stone usually deals with Anti-neutrophil cytoplasmic antibody and limits it to topics linked to Rituximab and Cyclophosphamide, Interleukin 6 and Azathioprine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
